Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
6,69 USD | -2,05% |
|
-7,60% | -19,49% |
09/05 | IGM BIOSCIENCES, INC. : Opinion positive de RBC Capital Markets | ZM |
08/05 | IGM Biosciences, Inc. fournit des prévisions de revenus pour le deuxième trimestre et l'année 2024 | CI |
Métier
Nombre d'employés: 216
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Engineered Immunoglobulin M Antibodies
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +99,25% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 2 | 100,0 % | +99,25% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 01/02/03 |
Misbah Tahir
DFI | Director of Finance/CFO | 49 | 01/01/19 |
T. S. Harigopal
COO | Chief Operating Officer | - | 01/01/21 |
Chris Takimoto
CTO | Chief Tech/Sci/R&D Officer | 65 | 29/07/21 |
Bruce Keyt
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/01/10 |
Lisa Wax
LAW | General Counsel | - | 01/01/21 |
Corporate Officer/Principal | - | 01/01/18 | |
George Gauthier
PRN | Corporate Officer/Principal | 52 | 12/04/21 |
Steven Weber
AUD | Comptroller/Controller/Auditor | 48 | 01/03/22 |
Paul Graffagnino
LAW | General Counsel | - | 01/01/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 26/01/21 |
M. Wilsey
BRD | Director/Board Member | 71 | 31/01/19 |
Fred Schwarzer
CEO | Chief Executive Officer | 72 | 01/02/03 |
Michael Lee
BRD | Director/Board Member | 45 | 01/07/19 |
Julie Hambleton
BRD | Director/Board Member | 66 | 15/08/18 |
Director/Board Member | 55 | 01/08/18 | |
Director/Board Member | 43 | 01/08/18 | |
William Strohl
BRD | Director/Board Member | 71 | 01/08/18 |
Director/Board Member | 49 | 03/10/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 25 386 983 | 0 | 0 | 37,37 % |
Action B | 1 | 33 636 592 | 22 059 861 ( 65,58 %) | 0 |
Coordonnées société
IGM Biosciences, Inc.
325 East Middlefield Road
94043, Mountain View
+650 965 7873
http://www.igmbio.com![Adresse IGM Biosciences, Inc.(IGMS)](https://cdn.zonebourse.com/static/address/65338650.png)
Secteur
![Consensus](/images/consensus_flch.gif)
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-19,49% | 395 M | |
+16,49% | 122 Md | |
+21,73% | 115 Md | |
+22,24% | 26,64 Md | |
-21,81% | 19,91 Md | |
-16,87% | 16,32 Md | |
-18,81% | 15,49 Md | |
-44,74% | 15,52 Md | |
+62,72% | 14,83 Md | |
+3,09% | 13,67 Md |
- Bourse
- Actions
- Action IGMS
- Société IGM Biosciences, Inc.